Tomorrow we'll know if and how we will proceed after the shareholder meeting. (Maybe Wednesday the latest in order to get a press release approved). It's been a wild ride, just like most of the early years in biotech before there is a viable product. Oncopet, FDA approval, China, India, Russia. That's my prediction. Time to refill the piggy bank and leave some for a rainy day. After last year, no one, even the best economists saw the house of cards come crashing down taking out companies that have been around for more than a hundred years. The fact that we have weathered the storm and will reemerge stronger and with more products to market and less debt, and more know-how from the 2 new board members IMO bodes very well for us. Let's see what tomorrow brings. The share is going to fluctuate until the official news is presented or Oncopet is launched.
